Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

featured

Published in Obesity, Metabolic Syndrome, and Prediabetes and

Expert Opinion / Interview · June 18, 2018

Cholesterol, Inflammation and Immunotherapy: Current Implications and Future Directions

Written by: Peter Libby MD
Interview by: Jennifer N. Caudle DO

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Sign in

Not a member?

Join for free

Additional Info

Disclosures

Disclosure statements are available on the authors' profiles:

Peter Libby MD

story of the week

Associations of Change in Body Fat Percentage With Baseline Body Composition and Diabetes Remission After Bariatric Surgery

Obesity · April 19, 2024

updated
story of the week

Semaglutide in Patients With Obesity-Related Heart Failure and Type 2 Diabetes

N. Engl. J. Med · April 18, 2024
story of the week

Cardiovascular and Kidney Risks in Individuals With Type 2 Diabetes

Diabetes Care · April 04, 2024
story of the week

Kidney Disease in Women With Previous Gestational Diabetes

Diabetes Care · March 25, 2024
story of the week

Impact of Canagliflozin on Kidney and Cardiovascular Outcomes by Type 2 Diabetes Duration

Diabetes Care · March 21, 2024
story of the week

Healthy Weight-Loss Maintenance With Exercise, GLP-1 Receptor Agonist, or Both Combined Followed by 1 Year Without Treatment

Lancet · March 15, 2024

updated
story of the week

Extension Study of the DiRECT Trial of Continued Support for Weight Loss Maintenance in the UK

Lancet Diabetes Endocrinol · March 11, 2024
story of the week

Comparison of Healthcare Costs Following Sleeve Gastrectomy vs Roux-en-Y Gastric Bypass in Patients With Type 2 Diabetes

Obesity · March 06, 2024

updated
story of the week

Impact of Remission From Type 2 Diabetes on Long-Term Health Outcomes

Diabetologia · March 04, 2024

updated
story of the week

Optimal Dose and Type of Physical Activity to Improve Glycemic Control in People Diagnosed With Type 2 Diabetes

Diabetes Care · February 24, 2024

updated
story of the week

Associations of Habitual Calcium Supplementation With Risk of CVD and Mortality in Individuals With and Without Diabetes

Diabetes Care · February 14, 2024

updated

Obesity, Metabolic Syndrome, and Prediabetes

Cholesterol, Inflammation and Immunotherapy: Current Implications and Future Directions

Additional Info

Further Reading

Associations of Change in Body Fat Percentage With Baseline Body Composition and Diabetes Remission After Bariatric Surgery

Semaglutide in Patients With Obesity-Related Heart Failure and Type 2 Diabetes

Cardiovascular and Kidney Risks in Individuals With Type 2 Diabetes

Kidney Disease in Women With Previous Gestational Diabetes

Impact of Canagliflozin on Kidney and Cardiovascular Outcomes by Type 2 Diabetes Duration

Healthy Weight-Loss Maintenance With Exercise, GLP-1 Receptor Agonist, or Both Combined Followed by 1 Year Without Treatment

Extension Study of the DiRECT Trial of Continued Support for Weight Loss Maintenance in the UK

Comparison of Healthcare Costs Following Sleeve Gastrectomy vs Roux-en-Y Gastric Bypass in Patients With Type 2 Diabetes

Impact of Remission From Type 2 Diabetes on Long-Term Health Outcomes

Optimal Dose and Type of Physical Activity to Improve Glycemic Control in People Diagnosed With Type 2 Diabetes

Associations of Habitual Calcium Supplementation With Risk of CVD and Mortality in Individuals With and Without Diabetes

Related Videos